In stockRetatrutide 10 mg
Lyophilized vial 10 mg
The Triple Agonist
$2,070MXN
NewGLP-1 Peptides
Semaglutide 5 mg
GLP-1 Agonist
$2,100MXN · VAT included
Presentation
- Presentation
- Lyophilized vial 5 mg
- Purity
- ≥99% HPLC
Long-acting GLP-1 analog for research on incretin signaling and glycemic homeostasis.
- Preclinical research
- High-purity analysis
Need help? Contact support.
HPLC ≥99%
Batch COA
Nationwide shipping
Notice: Product intended solely for in vitro scientific research. Not suitable for human or veterinary use.
Descripción general＋
Long-acting GLP-1 analog for research on incretin signaling and glycemic homeostasis.
Características＋
- •Preclinical research
- •High-purity analysis
Información técnica＋
- Pureza
- ≥99% HPLC
- Método analítico
- HPLC-UV 220 nm
- Identidad
- ESI-MS ±0.1 Da
- Producción
- Síntesis en fase sólida (SPPS)
- Presentación
- Lyophilized vial 5 mg
- Uso
- Research Use Only (RUO)
Conservación＋
Vial sellado: 2–8 °C a corto plazo; −20 °C para almacenamiento prolongado. Proteger de la luz y la humedad.
Vial reconstituido: 2–8 °C. Estabilidad orientativa 14–28 días según el péptido.
Evitar ciclos de congelación/descongelación. Descartar si se observa turbidez o precipitado.
Presentación＋
Lyophilized vial 5 mg
Presentaciones disponibles: 5 mg, 10 mg.
Empaque en vial sellado con septum de goma, etiqueta con lote y fecha de análisis.
Preguntas frecuentes＋
¿Cómo verifico la pureza del vial?
Cada lote se acompaña de un COA descargable con pureza HPLC ≥99%, identidad ESI-MS y número de lote trazable. También puedes verificar el lote en /verificar-lote.
¿Cuánto tarda el envío en México?
Los pedidos se despachan al día hábil siguiente y llegan típicamente en 24–72 h con paquetería nacional. Empaque discreto y con gel refrigerante cuando aplica.
¿Puedo cambiar la presentación?
Sí, si el producto tiene varias presentaciones (mg), aparecerán en el selector arriba. Para tamaños fuera de catálogo escríbenos por WhatsApp.
¿Este producto es para consumo humano?
No. Los productos son Research Use Only (RUO), destinados exclusivamente a investigación científica in vitro y modelos preclínicos.
Producto destinado únicamente a investigación científica in vitro. No apto para consumo humano ni veterinario.
What is Semaglutide?
Semaglutide is a long-acting synthetic GLP-1 analog used as a reference material in metabolic research. Its design enables controlled study of GLP-1R activation and its effects on incretin signaling, glucose homeostasis, satiety and energy balance. Peptide Life offers it lyophilized, with ≥99% HPLC purity, exclusively for in vitro scientific research.
GLP-1 mechanism
Semaglutide binds the GLP-1 receptor and activates signaling pathways associated with glucose-dependent insulin secretion, glucagon modulation, gastric emptying and central satiety signals. Its long-acting profile facilitates analysis of receptor response and metabolic variables over time in experimental models.
STEP 1 data
The phase 3 STEP 1 trial, published in The New England Journal of Medicine in 2021, documented a mean 14.9% body-weight reduction at 68 weeks with Semaglutide 2.4 mg, versus 2.4% with placebo. These clinical results contextualize its relevance as a GLP-1 reference standard, although the product offered by Peptide Life is for research only and not for human or veterinary use.
Technical specifications
| Parameter | Value |
|---|---|
| Name | Semaglutide |
| Classification | Selective GLP-1 receptor agonist |
| Presentation | Lyophilized vial 5 mg |
| Purity | ≥99% HPLC-UV 220 nm |
| Identity | ESI-MS ±0.1 Da |
| Storage | −20°C |
| Shelf life | ≥18 months |
| Use | Research use only (RUO) |
| Price | $2,100 MXN (VAT included) |
Frequently asked questions
How much does Semaglutide cost in Mexico?
$2,100 MXN for the 5 mg lyophilized vial, VAT included, with batch-verifiable COA and nationwide shipping.
What is Semaglutide studied for?
It is studied as a long-acting GLP-1 agonist in models of incretin signaling, glycemic homeostasis, satiety, energy balance and body composition.
What is the difference between Semaglutide and Retatrutide?
Semaglutide activates GLP-1R, while Retatrutide investigates coordinated activation of GLP-1R, GIPR and GCGR. See the full comparison.
